IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ligand Pharmaceuticals Inc

CUSIP: 53220KAF5 | 109 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

UBS Asset Management Americas LLC300,000
0.0% of portfolio›$298.7K
StyleTurnoverLocationFiled
UBS Asset Management Americas LLC
300,000$298.7K0.0%GrowthLowNew York, NY2023-08-11